We've found
9,144
archived clinical trials in
Ocular
We've found
9,144
archived clinical trials in
Ocular
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Feasibility Study of Retinal Screening Using the RetinaVue 100 Camera in Outpatient Dialysis Centers
Updated: 12/31/1969
A Feasibility Study of Retinal Screening Using the RetinaVue 100 Hand- Held (Non-mydriatic) Camera in Outpatient Dialysis Centers
Status: Enrolling
Updated: 12/31/1969
Feasibility Study of Retinal Screening Using the RetinaVue 100 Camera in Outpatient Dialysis Centers
Updated: 12/31/1969
A Feasibility Study of Retinal Screening Using the RetinaVue 100 Hand- Held (Non-mydriatic) Camera in Outpatient Dialysis Centers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Updated: 12/31/1969
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials